KRAS and non-small cell lung carcinoma: Metabolic regulators. Pyruvate dehydrogenase kinase 4 (PDK4), a gatekeeper of TCA cycle, is downregulated in MEKi resistant NSCLC cells 187, yet the role of metabolic regulators in driving KRAS targeted therapy resistance are still under exploited.